Syncona takes action to refocus operations at Autolus
Shares in life sciences company Syncona (SYNC) fell 2% to 263.5p on Wednesday after the company took action to refocus the drug development programme at Autolus, one of its quoted portfolio holdings.Chief executive Martin Murphy...
06 January 2021